Accumulating studies have demonstrated that METTL3 as a potential therapeutic target for cancers and virus infection (Hao et al., 2019; Zeng et al., 2020; Qiu et al., 2021; Yankova et al., 2021). This evidence concerns the gene METTL3 and viral infectious disease.